FISCALNOTE HOLDINGS INC (NOTE)

US3376551046 - Common Stock

1.15  +0.04 (+3.6%)

Fundamental Rating

1

Overall NOTE gets a fundamental rating of 1 out of 10. We evaluated NOTE against 81 industry peers in the Professional Services industry. NOTE may be in some trouble as it scores bad on both profitability and health. NOTE is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

NOTE had negative earnings in the past year.
In the past year NOTE has reported a negative cash flow from operations.

1.2 Ratios

With a Return On Assets value of -31.16%, NOTE is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -265.67%, NOTE is doing worse than 92.31% of the companies in the same industry.
Industry RankSector Rank
ROA -31.16%
ROE -265.67%
ROIC N/A
ROA(3y)-56.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 81.61%, NOTE belongs to the best of the industry, outperforming 89.74% of the companies in the same industry.
NOTE's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for NOTE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

NOTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NOTE has less shares outstanding
The debt/assets ratio for NOTE is higher compared to a year ago.

2.2 Solvency

NOTE has an Altman-Z score of -3.07. This is a bad value and indicates that NOTE is not financially healthy and even has some risk of bankruptcy.
NOTE has a worse Altman-Z score (-3.07) than 93.59% of its industry peers.
A Debt/Equity ratio of 5.12 is on the high side and indicates that NOTE has dependencies on debt financing.
NOTE has a Debt to Equity ratio of 5.12. This is amonst the worse of the industry: NOTE underperforms 91.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.12
Debt/FCF N/A
Altman-Z -3.07
ROIC/WACCN/A
WACC11.01%

2.3 Liquidity

A Current Ratio of 0.76 indicates that NOTE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.76, NOTE is doing worse than 87.18% of the companies in the same industry.
NOTE has a Quick Ratio of 0.76. This is a bad value and indicates that NOTE is not financially healthy enough and could expect problems in meeting its short term obligations.
NOTE has a Quick ratio of 0.76. This is amonst the worse of the industry: NOTE underperforms 87.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.00% over the past year.
Looking at the last year, NOTE shows a quite strong growth in Revenue. The Revenue has grown by 16.56% in the last year.
The Revenue has been growing by 26.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)16.56%
Revenue growth 3Y26.71%
Revenue growth 5YN/A
Sales Q2Q%-13.44%

3.2 Future

Based on estimates for the next years, NOTE will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.40% on average per year.
Based on estimates for the next years, NOTE will show a small growth in Revenue. The Revenue will grow by 1.07% on average per year.
EPS Next Y108.21%
EPS Next 2Y25.15%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue Next Year-9.88%
Revenue Next 2Y-3.18%
Revenue Next 3Y1.07%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOTE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOTE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NOTE's earnings are expected to grow with 18.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.15%
EPS Next 3Y18.4%

0

5. Dividend

5.1 Amount

No dividends for NOTE!.
Industry RankSector Rank
Dividend Yield N/A

FISCALNOTE HOLDINGS INC

NYSE:NOTE (12/23/2024, 9:54:59 AM)

1.15

+0.04 (+3.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners40.73%
Inst Owner Change5.87%
Ins Owners13.76%
Ins Owner Change0.16%
Market Cap166.39M
Analysts82
Price Target3.38 (193.91%)
Short Float %6.58%
Short Ratio9.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-57.84%
Min EPS beat(2)-148.28%
Max EPS beat(2)32.6%
EPS beat(4)2
Avg EPS beat(4)-46.3%
Min EPS beat(4)-148.28%
Max EPS beat(4)32.6%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.19%
Min Revenue beat(2)-3.67%
Max Revenue beat(2)-2.72%
Revenue beat(4)0
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-3.67%
Max Revenue beat(4)-2.5%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-8.7%
EPS NY rev (3m)132.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.96%
Revenue NY rev (3m)-25.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.25
P/FCF N/A
P/OCF N/A
P/B 3.83
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.92
BVpS0.3
TBVpS-1.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.16%
ROE -265.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.61%
FCFM N/A
ROA(3y)-56.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5YN/A
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 5.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.64%
Cap/Sales 5.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z -3.07
F-Score4
WACC11.01%
ROIC/WACCN/A
Cap/Depr(3y)38.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.56%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y108.21%
EPS Next 2Y25.15%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue 1Y (TTM)16.56%
Revenue growth 3Y26.71%
Revenue growth 5YN/A
Sales Q2Q%-13.44%
Revenue Next Year-9.88%
Revenue Next 2Y-3.18%
Revenue Next 3Y1.07%
Revenue Next 5YN/A
EBIT growth 1Y22.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.55%
EBIT Next 3Y30.77%
EBIT Next 5YN/A
FCF growth 1Y48.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.13%
OCF growth 3YN/A
OCF growth 5YN/A